These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7688401)

  • 1. Pathogenesis of the platinum (cp) mutation, a model for oculocutaneous albinism.
    Orlow SJ; Lamoreux ML; Pifko-Hirst S; Zhou BK
    J Invest Dermatol; 1993 Aug; 101(2):137-40. PubMed ID: 7688401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misrouting of tyrosinase with a truncated cytoplasmic tail as a result of the murine platinum (cp) mutation.
    Beermann F; Orlow SJ; Boissy RE; Schmidt A; Boissy YL; Lamoreux ML
    Exp Eye Res; 1995 Nov; 61(5):599-607. PubMed ID: 8654502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.
    Onojafe IF; Adams DR; Simeonov DR; Zhang J; Chan CC; Bernardini IM; Sergeev YV; Dolinska MB; Alur RP; Brilliant MH; Gahl WA; Brooks BP
    J Clin Invest; 2011 Oct; 121(10):3914-23. PubMed ID: 21968110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants.
    Halaban R; Cheng E; Hebert DN
    J Invest Dermatol; 2002 Aug; 119(2):481-8. PubMed ID: 12190874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New animal models to study the role of tyrosinase in normal retinal development.
    Lavado A; Montoliu L
    Front Biosci; 2006 Jan; 11():743-52. PubMed ID: 16146766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.
    King RA; Townsend D; Oetting W; Summers CG; Olds DP; White JG; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.
    Halaban R; Svedine S; Cheng E; Smicun Y; Aron R; Hebert DN
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5889-94. PubMed ID: 10823941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism.
    Giménez E; Lavado A; Giraldo P; Cozar P; Jeffery G; Montoliu L
    Pigment Cell Res; 2004 Aug; 17(4):363-70. PubMed ID: 15250938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversion mutation of ib oculocutaneous albinism to wild-type pigmentation in medaka fish.
    Iida A; Takamatsu N; Hori H; Wakamatsu Y; Shimada A; Shima A; Koga A
    Pigment Cell Res; 2005 Oct; 18(5):382-4. PubMed ID: 16162178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A frequent tyrosinase gene mutation in classic, tyrosinase-negative (type IA) oculocutaneous albinism.
    Giebel LB; Strunk KM; King RA; Hanifin JM; Spritz RA
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3255-8. PubMed ID: 1970634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
    Giebel LB; Musarella MA; Spritz RA
    J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism.
    Shimizu H
    Acta Derm Venereol; 1997 Jan; 77(1):10-3. PubMed ID: 9059668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of albinism in the rhesus monkey.
    Ding B; Ryder OA; Wang X; Bai SC; Zhou SQ; Zhang Y
    Mutat Res; 2000 Apr; 449(1-2):1-6. PubMed ID: 10751629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of oculocutaneous albinism.
    Oetting WS; King RA
    J Invest Dermatol; 1994 Nov; 103(5 Suppl):131S-136S. PubMed ID: 7963676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genetics of albinism.
    Searle AG
    Ophthalmic Paediatr Genet; 1990 Sep; 11(3):159-64. PubMed ID: 2126367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-molecular-weight forms of tyrosinase and the tyrosinase-related proteins: evidence for a melanogenic complex.
    Orlow SJ; Zhou BK; Chakraborty AK; Drucker M; Pifko-Hirst S; Pawelek JM
    J Invest Dermatol; 1994 Aug; 103(2):196-201. PubMed ID: 8040609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.